Company Overview
- Website
- nilogen.com
- Phone
- (813) 440-3588
- Employees
- 16
- Founded in
- 2013
- Industry
- BioTech/Drugs
- NAICS Codes
-
32 - Manufacturing325 - Chemical Manufacturing3254 - Pharmaceutical and Medicine Manufacturing32541 - Pharmaceutical and Medicine Manufacturing325413 - In-Vitro Diagnostic Substance Manufacturing54 - Professional, Scientific, and Technical Services541 - Professional, Scientific, and Technical Services
- SIC Codes
-
87 - Engineering, Accounting, Research, Management, and Related Services873 - Research, Development, and Testing Services
Financials & Stats
Revenue
$7B
Recent News & Media
Abstract CT098: Preliminary report of the TUMORIN Trial (using ex vivo tumoroids to predict immunotherapy response in NSCLC)
- Apr 25, 2025
- aacrjournals.org
Nilogen Oncosystems announces new Chief Scientific Officer
- Sep 15, 2023
- businesswire.com
The Spinoff Prize: where are they now?
- May 24, 2023
- nature.com
Abstract 4571: A novel ex vivo platform, 3D-EXpress, to rapidly assess the efficacy of KRAS targeting drugs alone and in combination with nivolumab using a biorepository of fresh patient tumoroids with intact tumor microenvironment
- Apr 4, 2023
- aacrjournals.org
Nilogen Oncosystems Announces Opening of Clinical Trial Using Ex Vivo Tumoroids to Predict Immunotherapy Response in Non-Small Cell Lung Cancer (TUMORIN)
- Jul 28, 2022
- biospace.com
Nilogen Oncosystems Announces Partnership with Scailyte AG to Provide Clinically Relevant Translational Platform Supporting Development of Immuno-Oncology Therapeutics in Oncology Clinical Trials and Ultimately to Support Personalized Medicine for P
- Jul 12, 2022
- prnewswire.com
Who is Nilogen Oncosystems
Nilogen Oncosystems is a biotechnology company located in Tampa, Florida. Founded with a mission to revolutionize drug development, Nilogen employs 16 individuals and generates approximately $7 million in annual revenue. Nilogen specializes in providing innovative preclinical drug testing platforms for cancer and immuno-oncology research. Their unique approach utilizes fresh patient tumor samples, preserving the intact tumor immune microenvironment, allowing for a comprehensive understanding of drug sensitivity and resistance mechanisms. What sets Nilogen apart is its commitment to customization. Their proprietary platforms are tailored to each client's specific needs, aiming to significantly reduce the costs and risks associated with clinical trials. Interested parties can learn more about Nilogen's groundbreaking solutions and services by visiting their website at nilogen.com.
Company Leadership
Nilogen Oncosystems Tech Stack
Companies Similar to Nilogen Oncosystems
Analyze industry trends and opportunities by examining competitors and companies comparable to Nilogen Oncosystems, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 7M | 107 | Boston, MA | 2001 | |
| 7M | 2 | Lubbock, TX | ||
| 7M | 50 | Durham, NC | 2014 | |
| 7M | 3 | Orlando, FL | 1995 | |
| 7M | 70 | Sarasota, FL | 2003 |